# Stereotaxis: company

Canonical ID: `e401d2c7-b035-4dea-9b60-ae0d2bb9b99b`

## Key facts

- **Product:** Genesis RMN / GenesisX robotic magnetic navigation + MAGiC ablation catheter (electrophysiology).
- **Gating events:** GenesisX CE Aug 2024 + FDA 510(k) Nov 10 2025; MAGiC FDA Jan 6 2026.

- **Slug:** stereotaxis
- **Status:** public (NYSE American: STXS)
- **Founded:** 1990
- **HQ:** St. Louis, Missouri, USA

## Models

- [Genesis RMN / GenesisX](/models/stereotaxis-genesis.md) (surgical) (id: `eca99ad0-d6db-401f-9575-6e22a77bfc14`)

## Supplies to

_No verified supply relationships on file. Supply-chain coverage is being added across the registry; check back as the seed populates this company's outbound edges._

_Outbound supply edges. Each appears when verified with at least two strong sources. Sources are append-only; corrections add new sources rather than rewrite history._

## Sources (3)

1. https://www.globenewswire.com/news-release/2025/11/10/stereotaxis-genesisx-fda-clearance
2. https://www.globenewswire.com/news-release/2026/01/06/stereotaxis-magic-catheter-fda
3. https://www.globenewswire.com/news-release/2026/05/12/stereotaxis-q1-2026-results

_API: GET /v1/companies/e401d2c7-b035-4dea-9b60-ae0d2bb9b99b · canonical URL: /companies/stereotaxis_